Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

BofA has lowered its rating of Hims & Hers (NYSE:HIMS) to underperform from buy, citing Amazon’s (AMZN) push into the hair ...

The move places the company in competition with other direct-to-consumer marketplaces including Hims & Hers Health and Ro.

Hims & Hers (HIMS) is down -17.7%, or -$4.88 to $22.72. Published first on TheFly – the ultimate source for real-time, ...

Amazon (AMZN) has been steadily expanding into healthcare, and now it’s setting its sights on telehealth companies like Hims ...

Amazon One Medical is expanding its telehealth services with the launch of upfront and low-cost treatment plans and ...

FDA’s requirement for truthful, balanced risk and benefit information applies to drugmakers, leaving a loophole for both ...

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

Hims & Hers (HIMS) fell 17% Thursday after Amazon (AMZN) announced it was launching an expanded pay-per-visit telehealth ...

In response to the FDA’s shortage decision, Hims & Hers is launching a new GLP-1 tracker, allowing patients to self-identify, provide ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...